E70.81

HCC Category Mapping

What This Code Means

A rare genetic disorder where the enzyme aromatic L-amino acid decarboxylase is deficient, affecting the production of important neurotransmitters like dopamine and serotonin.

Coding Tips

• •This is a specific neurometabolic disorder; document associated neurological symptoms such as developmental delay, movement disorders, or autonomic dysfunction
• •Often presents in infancy with severe neurological manifestations; ensure comprehensive documentation of clinical presentation

Clinical Significance

Aromatic L-amino acid decarboxylase deficiency is a rare, severe neurometabolic disorder that impairs the synthesis of dopamine, serotonin, epinephrine, and norepinephrine. Affected infants present with severe developmental delay, oculogyric crises, dystonia, ptosis, autonomic dysfunction (temperature instability, excessive sweating, nasal congestion), and hypotonia. Gene therapy (eladocagene exuparvovec) has recently become available as a treatment option.

Documentation Requirements

• ✓Documentation must include confirmed diagnosis through cerebrospinal fluid neurotransmitter analysis showing low dopamine and serotonin metabolites with elevated L-dopa and 5-hydroxytryptophan, enzyme activity assay, or genetic testing of the DDC gene.
• ✓The severity of neurological manifestations, current medication regimen (dopamine agonists, monoamine oxidase inhibitors, pyridoxine), and functional status should be detailed.
• ✓If gene therapy has been administered, document the treatment and response.

Commonly Confused Codes